Related Experiment Video

Updated: Feb 7, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.5K

Micelle-like nanoparticles as siRNA and miRNA carriers for cancer therapy

Daniel F Costa1,2, Vladimir P Torchilin3

  • 1Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston, MA, 02115, USA.

Biomedical Microdevices
|July 13, 2018
PubMed

Insights

Gene therapy using RNA interference offers a new cancer treatment. Micelle-like nanoparticles show promise for overcoming challenges in delivering small interfering RNAs (siRNA) and microRNAs (miRNA) in vivo.

Area of Science:

  • Oncology
  • Molecular Biology
  • Nanotechnology

Background:

  • Cancer treatment resistance to chemotherapy and radiotherapy necessitates novel therapeutic strategies.
  • Small non-coding RNAs, including siRNA and miRNA, present versatile mechanisms for gene therapy.
  • In vivo application of RNA therapeutics is limited by biological instability and immunogenicity.

Purpose of the Study:

  • To review RNA interference (RNAi) in cancer therapy, focusing on siRNA and miRNA.
  • To discuss challenges associated with in vivo delivery of RNA therapeutics.
  • To introduce micelle-like nanoparticles as a potential drug delivery system for RNA gene therapy.

Main Methods:

  • Literature review of RNA interference in cancer therapy.
  • Exploration of small interfering RNA (siRNA) and microRNA (miRNA) roles.
  • Analysis of micelle-like nanoparticle synthesis and advantages for gene delivery.

Main Results:

  • RNA interference, utilizing siRNA and miRNA, is a viable approach for cancer treatment.
  • In vivo delivery of RNA remains a significant hurdle due to instability and immune responses.
  • Micelle-like nanoparticles demonstrate potential for overcoming these delivery challenges.

Conclusions:

  • Micelle-like nanoparticles represent a promising system for enhancing RNA gene therapy efficacy.
  • Further research into micelle-like nanoparticles is warranted for in vitro, in vivo, and clinical applications.
  • Advancements in nanoparticle delivery systems are crucial for realizing the full potential of RNA-based cancer therapies.
Keywords:
CancerMicelle-like nanoparticlesPolymersmiRNAsiRNA

More Related Videos

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery09:09

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery

Published on: May 2, 2019

8.0K
Preparation of Exosomes for siRNA Delivery to Cancer Cells09:59

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

26.1K

Related Concept Videos

Electron Carriers01:24

Electron Carriers

Electron carriers can be thought of as electron shuttles. These compounds can easily accept electrons (i.e., be reduced) or lose them (i.e., be oxidized). They play an essential role in energy production because cellular respiration is contingent on the flow of electrons.
Over the many stages of cellular respiration, glucose breaks down into carbon dioxide and water. Electron carriers pick up electrons lost by glucose in these reactions, temporarily storing and releasing them into the electron...
91.9K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
Carrier Transport01:21

Carrier Transport

The generation of electrical current in semiconductors is fundamentally driven by two mechanisms: drift and diffusion. These processes are essential for the functionality and performance of semiconductor-based devices.
Drift Current:
The drift of charge carriers is started by an external electric field (E). Charged particles, such as electrons and holes, experience an acceleration between collisions with lattice atoms. For electrons, this results in a drift velocity (vd) given by:
969
The ADP/ATP Carrier Protein01:42

The ADP/ATP Carrier Protein

ADP/ATP carrier or AAC protein is the most abundant carrier protein in the inner mitochondrial membrane. It transports large quantities of ADP and ATP, equivalent to the average human body weight, every day. Among other transporters, ACC protein is one of the best-studied members of the mitochondrial carrier protein family. The ADP/ATP carrier protein comprises two transmembrane helices connected to a loop and a single alpha-helix on the matrix side. It switches between two conformational...
4.3K